Cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract against A549 (Human Lung Adenocarcinoma) cell line

Cancer is a leading issue within the medical community and in the world, specifically lung cancer cells which affect thousands of people each day. Hence, this study aims to investigate the cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract/sample that has not yet been studied against lung cancer cells. A. squamosa (Atis) leaf extract was acquired through maceration and then tested using MTT Cytotoxicity Assay to determine % inhibition and the half maximal inhibitory concentration (IC50) after exposure to the extract and Annexin V-Propidium Iodide (PI) Staining Assay to determine the percentage of cells undergoing early and late apoptosis and necrosis. Testing was conducted on the A549 (human lung adenocarcinoma) cell line in UP Diliman Mammalian Cell Culture Laboratory. Among the concentrations, 1.5625 ug/mL resulted in the highest % inhibition and was highly cytotoxic against the A549 cells while the 100 ug/ml concentration resulted in the higher % total cell death and % early and late apoptosis compared to the 1.5625 ug/mL concentrations. Therefore, A. squamosa (Atis) leaf extract may be developed into a potentially sustainable and affordable novel drug for treating A549 (human lung adenocarcinoma) cells in the future.

Publication Details

Journal
International Journal of Biosciences (IJB)
Published
2025-08-20
DOI
https://doi.org/10.12692/ijb/27.2.226-235
Primary Topic
Traditional and Medicinal Uses of Annonaceae
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract against A549 (Human Lung Adenocarcinoma) cell line

1 links
International Journal of Biosciences (IJB)
Traditional and Medicinal Uses of Annonaceae
article

Cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract against A549 (Human Lung Adenocarcinoma) cell line

article en

Abstract

Cancer is a leading issue within the medical community and in the world, specifically lung cancer cells which affect thousands of people each day. Hence, this study aims to investigate the cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract/sample that has not yet been studied against lung cancer cells. A. squamosa (Atis) leaf extract was acquired through maceration and then tested using MTT Cytotoxicity Assay to determine % inhibition and the half maximal inhibitory concentration (IC50) after exposure to the extract and Annexin V-Propidium Iodide (PI) Staining Assay to determine the percentage of cells undergoing early and late apoptosis and necrosis. Testing was conducted on the A549 (human lung adenocarcinoma) cell line in UP Diliman Mammalian Cell Culture Laboratory. Among the concentrations, 1.5625 ug/mL resulted in the highest % inhibition and was highly cytotoxic against the A549 cells while the 100 ug/ml concentration resulted in the higher % total cell death and % early and late apoptosis compared to the 1.5625 ug/mL concentrations. Therefore, A. squamosa (Atis) leaf extract may be developed into a potentially sustainable and affordable novel drug for treating A549 (human lung adenocarcinoma) cells in the future.

International Journal of Biosciences (IJB)
University of the Philippines
Openalex Percentile: Top 77%
Traditional and Medicinal Uses of Annonaceae
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cytotoxic and apoptotic effects of Annona squamosa (Atis) crude leaf extract against A549 (Human Lung Adenocarcinoma) cell line · International Journal of Biosciences (IJB) (2025) | TGRS Research Map | TGRS